(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 5.44% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Align Technology's revenue in 2025 is $3,980,843,000.On average, 6 Wall Street analysts forecast ALGN's revenue for 2025 to be $301,118,338,603, with the lowest ALGN revenue forecast at $300,022,005,383, and the highest ALGN revenue forecast at $302,841,665,698. On average, 6 Wall Street analysts forecast ALGN's revenue for 2026 to be $318,689,606,365, with the lowest ALGN revenue forecast at $317,885,169,599, and the highest ALGN revenue forecast at $321,136,114,718.
In 2027, ALGN is forecast to generate $339,094,451,530 in revenue, with the lowest revenue forecast at $339,076,837,714 and the highest revenue forecast at $339,127,577,103.